Beds, bedrooms, bedding, and bugs: anything new between the sheets?

PubWeight™: 0.79‹?›

🔗 View Article (PMID 8955568)

Published in Clin Exp Allergy on November 01, 1996

Authors

R W Siebers, P Fitzharris, J Crane

Articles by these authors

International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01

End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87

Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39

Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39

Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02

Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis (1990) 2.81

The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61

Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61

Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54

Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15

Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06

Baseline risk for asthma deaths. N Z Med J (1992) 2.02

Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96

Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94

Receptor-triggered membrane association of a model retroviral glycoprotein. Proc Natl Acad Sci U S A (1998) 1.91

House dust mite allergen (Der p 1) accumulation on new synthetic and feather pillows. Clin Exp Allergy (1999) 1.89

Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84

House dust mite allergen in pillows. BMJ (1996) 1.83

Obesity and asthma in 11-12 year old New Zealand children in 1989 and 2000. Thorax (2005) 1.82

The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79

Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76

The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72

The importance of housing characteristics in determining Der p 1 levels in carpets in New Zealand homes. Clin Exp Allergy (2001) 1.61

Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57

Risk factors for asthma symptoms in Kawerau children. N Z Med J (1994) 1.56

Managing acute anaphylaxis. New guidelines emphasise importance of intramuscular adrenaline. BMJ (1999) 1.52

Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51

Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49

The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48

Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine? J Epidemiol Community Health (2002) 1.46

Selenium status and allergic disease in a cohort of New Zealand children. Clin Exp Allergy (2012) 1.45

Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43

Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42

Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust (1990) 1.41

Increasing asthma prevalence in a rural New Zealand adolescent population: 1975-89. Arch Dis Child (1990) 1.39

Fenoterol and asthma death. N Z Med J (1989) 1.39

The effects of carbon dioxide on exercise-induced asthma: an unlikely explanation for the effects of Buteyko breathing training. Med J Aust (2001) 1.39

Asthma and regular beta agonist therapy. N Z Med J (1991) 1.39

Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax (1997) 1.39

Asthma deaths in New Zealand. BMJ (1992) 1.38

Fenoterol: confounding again. N Z Med J (1989) 1.38

Inappropriate use of inhaled beta agonists in asthma. N Z Med J (1990) 1.37

Prescribing for childhood asthma in the Wellington area: comparison with international guidelines. N Z Med J (1993) 1.37

Farm residence and exposures and the risk of allergic diseases in New Zealand children. Allergy (2002) 1.36

Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med (1994) 1.36

The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr) (2012) 1.26

Measuring the prevalence of bronchial hyper-responsiveness in children. Int J Epidemiol (1995) 1.24

Comparison of a video questionnaire with the IUATLD written questionnaire for measuring asthma prevalence. Clin Exp Allergy (1992) 1.23

Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor. J Virol (1999) 1.21

Cat allergen levels in public places in New Zealand. N Z Med J (1998) 1.18

The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J (1990) 1.18

Fast foods - are they a risk factor for asthma? Allergy (2005) 1.18

Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol (1999) 1.18

A questionnaire survey of stress and bullying in doctors undertaking research. Postgrad Med J (2004) 1.16

Cat allergen (Fel d 1) levels on school children's clothing and in primary school classrooms in Wellington, New Zealand. J Allergy Clin Immunol (1997) 1.15

Passive smoking in children: effect of avoidance strategies, at home as measured by hair nicotine levels. Arch Environ Health (2001) 1.14

Questionnaire and hair measurement of exposure to tobacco smoke. J Expo Anal Environ Epidemiol (2000) 1.12

Family size, infections, and asthma prevalence in New Zealand children. Epidemiology (1999) 1.12

Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity. N Z Med J (1993) 1.10

House dust-mite allergen and cat allergen variability within carpeted living room floors in domestic dwellings. Indoor Air (2003) 1.08

House dust-mite allergen and cat allergen variability within carpeted living room floors in domestic dwellings. Indoor Air (2003) 1.07

The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New Zealand. J Allergy Clin Immunol (1999) 1.05

Kinetics of specific in vitro antibody production following influenza immunization. Clin Exp Immunol (1982) 1.05

Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy (2008) 1.03

Trial of an asthma action plan in the Maori community of the Wairarapa. N Z Med J (1993) 1.02

A multi-centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2. Clin Exp Allergy (2009) 1.02

The association of early life exposure to antibiotics and the development of asthma, eczema and atopy in a birth cohort: confounding or causality? Clin Exp Allergy (2008) 1.01

A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy (2012) 1.00

A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Curr Med Res Opin (1993) 1.00

Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J (1994) 1.00

Chronic bronchitis, shortness of breath, and airway obstruction by occupation in New Zealand. Am J Respir Crit Care Med (1997) 0.99

Fenoterol and asthma mortality. Lancet (1989) 0.99

Comparison of two dust collection methods for reservoir indoor allergens and endotoxin on carpets and mattresses. Indoor Air (2004) 0.99

Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy (1994) 0.99

Problems of measuring asthma prevalence. Respirology (1996) 0.99

Asthma and allergic symptoms in relation to house dust endotoxin: Phase Two of the International Study on Asthma and Allergies in Childhood (ISAAC II). Clin Exp Allergy (2008) 0.99

Prevalence of adult asthma symptoms in relation to climate in New Zealand. Environ Health Perspect (1998) 0.99

Pattern of injury in those dying from traumatic amputation caused by bomb blast. Br J Surg (1994) 0.99

Closing the gap between GPs and hospitals. Br Med J (1980) 0.99

The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N Z Med J (2001) 0.99

Determinants of endotoxin levels in carpets in New Zealand homes. Indoor Air (2003) 0.98

A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. Eur Respir J (1993) 0.98

The role of paracetamol in the pathogenesis of asthma. Clin Exp Allergy (2010) 0.98